GOOG
61
-4
UHS
54
-6
LB
69
5
IPG
35
-4
ZBH
71
6
PNW
52
-3
AON
34
-2
NI
56
-7
REGN
39
-5
HBAN
39
-9
PBI
32
-3
AMT
24
-4
LRCX
55
-6
AFL
34
-8
AKAM
32
-5
GM
44
-3
AEE
58
-5
MCO
61
-7
ICE
42
-4
PVH
40
-8
GOOG
61
-4
UHS
54
-6
LB
69
5
IPG
35
-4
ZBH
71
6
PNW
52
-3
AON
34
-2
NI
56
-7
REGN
39
-5
HBAN
39
-9
PBI
32
-3
AMT
24
-4
LRCX
55
-6
AFL
34
-8
AKAM
32
-5
GM
44
-3
AEE
58
-5
MCO
61
-7
ICE
42
-4
PVH
40
-8
Financhill
Back

Pathward Financial Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
39

CASH
Pathward Financial

Last Price:
$72.06
Seasonality Move:
2.16%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
39
Pathward Financial (CASH) is a Sell

Is Pathward Financial a Buy, Sell or Hold?

  • The current Pathward Financial [CASH] share price is $72.20. The Score for CASH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CASH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CASH Stock Price Chart

What is Pathward Financial's stock price today?

  • The Pathward Financial share price today is $72.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASH is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

CASH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.65 Sell
Relative Strength Index (14 RSI): 34.4 Sell
Chaikin Money Flow: -27145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.15 - 81.81) Sell
Bollinger Bands (100): (66.55 - 79.49) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

CASH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.72 Sell
20-day SMA: 75.95 Sell
50-day SMA: 78.2 Sell
200-day SMA: 64.36 Buy
8-day EMA: 73.91 Sell
20-day EMA: 75.63 Sell
50-day EMA: 76.1 Sell
200-day EMA: 66.93 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

Pathward Financial Earnings Growth & CASH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $0.97 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Pathward Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):